Home » Topics » Disease categories and therapies » Infection

Infection
RSS

SBIR grant to Phytera for antibacterial drug discovery technology

April 12, 1999

Liposomal amphotericin B effective for empirical antifungal therapy

April 12, 1999

Anti-CMV activity of BDCRB evaluated in newly designed preclinical model

April 9, 1999

RPR-CMV-423: a promising candidate for treatment of human CMV infection

April 9, 1999

Versicor and Pharmacia & Upjohn join forces for development of new oxazolidinones

April 9, 1999

FDA decides to continue review of Relenza NDA

April 8, 1999

Production and activity of new antimicrobial compound described by Teijin

April 8, 1999

Novel antibiotic active against acid-fast bacteria presented at recent Japanese congress

April 7, 1999

New carbapenems synthesized at Merck useful against resistant staphylococci

April 7, 1999

International team identifies myristic acid analogues with antipicornaviral activity

March 31, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.